NurExone Announces Closing of a Private Placement for Gross
TORONTO and HAIFA, Israel , Jan. 05, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or...
Terns Pharmaceuticals Reports Inducement Grant to New
FOSTER CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
Voyager Therapeutics Announces Pricing of Public Offering
LEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today...
Tuttle Capital Management Launches 2x Inverse Regional Bank
GREENWICH, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE) -- via IBN -- The 2x Inverse Regional Bank ETF, (NASDAQ: SKRE), will start trading...
Hub Group, Inc. 2-for-1 Stock Split
OAK BROOK, Ill., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Hub Group, Inc. (NASDAQ: HUBG) today announced a 2-for-1 stock split of its...
Homology Medicines Receives NASDAQ Notification Regarding
Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement BEDFORD, Mass.,...
Eterna Therapeutics Grants New President and CEO Sanjeev
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed...
Global Systems Dynamics, Inc.’s Provides Update on Nasdaq
HOUSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Global System Dynamics, Inc. (Nasdaq: GSD, GSDWW, GSDWU) (“GSD” or the “Company”) today provided an...
XBP Europe to Ring Nasdaq Opening Bell on January 5, 2024
LONDON and NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- XBP Europe (“XBP” or the “Company”) (NASDAQ: XBP and XBPEW), today announced...
SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
SIOUX FALLS, S.D., Jan. 02, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform...
ARHT Media Inc. Issues Shares Related to Semi-Annual
TORONTO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- ARHT Media Inc. ("ARHT" or "the Company") (TSXV: ART), (OTCQB: ARHTF) the global leader in...
Bluejay Diagnostics Announces Closing of $3.5 Million
ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing...
